Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobic
| Image |  |
|---|---|
| Description | scientific article published on 04 July 2019 |
| Author/s |
author: Joseph J Eron Stéphane De Wit |
| Publication date | July 4, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |